BRCA1 and BRCA2 are well-characterized breast cancer susceptibility genes and it is well established that mutations in these genes impair the homologous recombination–mediated DNA repair pathway, which is required to maintain genomic integrity (1). This evidence concerns the gene BRCA2 and breast cancer.